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Abstract Libraries of monovalent display-phage expressing 
mutant human B-type natriuretic peptide (hBNP) were used to 
identify variants that preferentially bind natriuretic peptide 
receptor-A (NPR-A) compared to receptor-C (NPR-C). Position 
19 was a significant determinant of receptor specificity for hBNP 
display phage. The synthetic hBNP variant S19R had a 265-fold 
improved NPR-A binding over NPR-C, analogous to the atrial 
natriuretic peptide (ANP) specificity mutation G16R. Mutation 
of the last three residues of the hBNP disulfide ring, G23F/ 
L24W/G25R, resulted in about 9-fold improved selectivity. The 
analogous mutations in ANP decreased NPR-A binding, 
suggesting divergence in the mechanism of NPR-A recognition. 
© 1997 Federation of European Biochemical Societies. 
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!. Introduction 
B-type natriuretic peptide (BNP) is a member of a family of 
related polypeptide hormones that includes ANP and CNP 
[1,2]. Both ANP and BNP are produced by atrial myocytes, 
and by ventricular myocytes under conditions of increased 
load [3,4]. Two receptors have been described for these car- 
diac hormones. NPR-A,  or guanylyl cyclase-A, directly syn- 
thesizes the second messenger cGMP in response to ligand 
binding [5]. The second receptor, NPR-C  or the clearance 
receptor, functions in the internalization and degradation of 
bound ligand, and may be involved in signal transduct ion 
[6,7]. 
In this report we investigated the determinants of hBNP 
receptor selectivity by monovalent  phage display [8,9] of libra- 
ries of mutant  hBNP molecules. Using receptor extracellular 
domain- IgG fusions as binding targets we selected for hBNP 
variants that selectively bound A- IgG in the presence of excess 
competing C-IgG. Our results indicate similarities and differ- 
ences between receptor-selectivity mutat ions in hANP and 
hBNP, and suggest hat NPR-A  recognition of these homol- 
ogous polypeptides is not identical. 
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Abbreviations." hANP,  human atr ial  natr iuret ic  peptide; 
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natriuretic peptide; BNP(GR14), hBNP(R13G, KI4R); BNP(R19), 
hBNP(SI9R): BNP(FWR25), hBNP(G23F, L24W, G25R); NPR, 
natriuretic peptide receptor; A-IgG, NPR-A extracellular/IgG heavy 
chain fusion protein; C-IgG, NPR-C/IgG fusion protein 
2. Materials and methods 
2.1. Construction of BNP display phage 
Phagemid encoding the hBNP fusion with M I3 glIl was made from 
the ANP phagemid vector [9] by site-directed mutagenesis [10]. Libra- 
ries of mutant hBNP molecules with randomization of from 3 to 
4 codons were constructed using primer-directed mutagenesis 
with the following oligonucleotides: positions 11 14, 5'-GTGCA- 
GGGTTCTGGTTGCNNSNNSNNSNNSATGGATCGTATCAGC- 
TCC-3'; positions 15 18, 5'-GGTTGCTTCGGCAGAAAGNNSN- 
NSNN SNNSAGCTCCAGCAGCGGTCTC-Y: positions 19-22, 
5'-AAGATGGATCGTATCNNSNNSNNSNN SGGTCTCGGGTG- 
CAAAGTG-3': positions 23 25, 5'-CGTATCAGCTCCAGCAG- 
CNNSNNSNNSTGCAAAGTGCT GCGTCGT-3'. The libraries 
were made with template DNA that contained frameshift mutations 
to prevent hBNP background in the initial library. 
2.2. Competitive panning./or hNPR-A selective hBNP variants 
Competitive selection of hBNP variants with hNPR-A and hNPR- 
C was done with receptor extracellular domain-lgG fusions, referred 
to as A-IgG and C-IgG [11]. Phage libraries went through one round 
of enrichment for A-IgG binding before introducing negative compet- 
itive binding pressure with C-IgG. For both enrichment and compet- 
itive selection, wells of Nunc Maxisorb microtiter plates (catalog no. 
4-39454) were coated with 100 ial of 2 gg/ml rabbit anti-human Fc 
antibody (Jackson ImmunoResearch atalog no. 309-006-008) in coat 
buffer (50 mM carbonate, pH 9.6) overnight at 4°C. The coat solution 
was discarded and the wells were incubated for 1 h at room temper- 
ature with 25 mM carbonate pH 9.6 in 5% skim milk to block non- 
specific binding. After washing with 0.01% (v/v) Tween 20 in phos- 
phate buffered saline (PBS), A-IgG was added at 1 gg/ml in binding 
buffer [2% (w/v) skim milk in phosphate buffered saline (PBS)] for 1 h 
at room temperature then washed once in binding buffer. For enrich- 
ment 10 gl of phage library stock (250 fold concentrated from growth 
medium, stored in PBS at 4°C) was diluted to 100 gl in binding buffer 
and incubated in the A-IgG coated wells for 2 h at room temperature. 
After washing 20 30 times the bound phage was recovered by adding 
100 gl of 0.2 M glycine pH 2.0 to the wells for 1 m and neutralizing 
with t00 gl of 1.0 M Tris base. The recovered phage was mixed with 
1.0 ml of E. coli XLl-blue cells (Stratagene) in log growth phase, and 
grown for 80 min at 37°C with shaking. KO7 helper phage was added 
and the culture was grown for an additional 30 min. The infected 
culture was transferred to 25ml of 2YT media (with 50 ~tg/ml carbe- 
nicillin and 5 gg/ml tetracycline) and grown overnight at 37°C. Phage 
particles were recovered by two polyethyleneglycol/NaCl precipita- 
tions and resuspended in 100 lal of PBS for the next round of selec- 
tion. Competitive selection was done in seven rounds, with increasing 
amounts (20 nM to 200 nM) of C-IgG included at successive cycles. 
Individual clones were picked and the measurement of phagemid re- 
ceptor affinity by ELISA was essentially as described [9] with the 
following modifications: phage binding buffer was 2% (w/v) skim 
milk in PBS and the anti-phage antibody was Sheep anti-M13 horse 
radish peroxidase conjugate (Pharmacia/. 
2.3. Peptide affinities and agonist potency 
Membranes from 293 cell lines stably expressing NPR-A [12] or 
NPR-C [9] were prepared and tested for ligand binding essentially 
as described [13]. Briefly, membrane samples were diluted in 50 mM 
HEPES, 5 mM MgClz, 100 mM NaC1, 0.1 mM EDTA, 0.2'¼, (w/v) 
BSA, 1 gM phosphoramidon, and added to an equal volume of syn- 
thetic peptide plus 30 pM [12~I]rANP (3000 Ci/mmole, Amersham 
0014-5793197/$17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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Corp). The binding was allowed to go for 2 h at room temperature in 
96 well U-bottom polypropylene microtiter plates (Sigma), with gentle 
agitation. Bound ligand was separated from free prior to scintillation 
counting, as previously described [13]. Assays were set up in duplicate 
and repeated three times. Concentration-response experiments for 
stimulation of cGMP production in 293 cells expressing hNPR-A 
were set up and analyzed as before [14]. Stimulations were performed 
in triplicate and assayed in duplicate for cGMP production. Results 
from competition binding and cGMP stimulation experiments were 
analyzed by a four parameter logistics equation. 
3. Resu l ts  
3.1. Identification of NPR-A selective phagemid clones 
Libraries of mutant hBNP display phage were constructed 
by primer directed mutagenesis and subjected to seven rounds 
of competitive panning to identify NPR-A selective variants 
with reduced NPR-C binding. The 32-amino acid hBNP se- 
quence (Fig. 1) was divided into mutagenesis windows cover- 
ing the N- and C-terminal tail sequences and the 17 amino 
acid ring. No receptor selectivity mutations were found in the 
tail sequences (data not shown), however 3 of the 4 muta- 
genesis windows in the disulfide ring did provide amino acid 
changes imparting receptor selectivity (Table I). Individual 
phagemid clones were sequenced and tested for binding to 
A-IgG (Table 1). Representative clones that retained A-IgG 
binding were then tested for preferential receptor binding by 
phage ELISA (Fig. 2). Mutagenesis window A was sorted to 
two sequences, only one of which, sequence 1, showed binding 
to A-IgG by phage ELISA (Table 1, Fig. 2). This clone had 
the misincorporation mutation S19R outside of the mutagen- 
esis window, directly analogous to the G16R misincorpora- 
tion mutation found in ANP display phage [9]. Interestingly 
this mutation was accompanied by mutations R13G and 
K14R that change this hBNP sequence to the corresponding 
ANP sequence (Fig. 1). By phage ELISA this sequence had 
reduced C-IgG binding (Fig. 2). 
Mutagenesis window B did not provide NPR-A selective 
clones, whereas window C was also characterized by the pres- 
ence of a misincorporation mutation, at position 14, outside 
the target mutagenesis region (Table 1). Window C clones had 
a basic amino acid substituted at either or both of position 19 
or 20, and a misincorporation change in the basic amino acid 
K14 to a polar residue. Phagemid clones from this mutagen- 
esis window retained A-IgG binding and had reduced binding 
to C-IgG (Table 1, Fig. 2). 
The last 3 amino acids in the ring, covered in mutagenesis 
window D, were selected to an apparent consensus equence 
unlike anything previously seen in the natriuretic peptides 
(Table 1). The clones obtained were dominated by the muta- 
tions MWR and FWR. These phagemid clones all retained A- 
IgG binding and the most abundant sequences had signifi- 
cantly reduced binding to C-IgG (Table 2, Fig. 2). 
3.2. Receptor affinities of synthetic hBNP variants 
Synthetic peptides incorporating mutations identified by 
hANP ~S L R R~S G R G A 0 N S F y28 
{I 
hBNP IS P K M V O G~G~R K S S S K V L~R H 32 
Fig. 1. Comparison of human ANP and BNP sequences. Identical 
residues are boxed. The 17 amino acid ring-forming disulfide bond 
is indicated by a line at the top. 
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Fig. 2. Phage ELISA. Individual phagemid clones were incubated 
with immobilized A-IgG in the presence of increasing concentrations 
of solution-phase A-IgG (A) or C-IgG (B). The key in panel A cor- 
responds to individual phagemid sequences in Table 1. 
monovalent phage display were prepared in order to confirm 
the results of phage ELISA assays on receptor selectivity. 
Using hBNP and hANP as reference peptides, we compared 
the effect of the mutations in competitive binding assays using 
membranes from 293 cells expressing recombinant hNPR-A 
or hNPR-C (Table 2). The first series of peptides, BNP(GR14/ 
R19), BNP(GR14), and BNP(R19), were designed to address 
the role of mutations in window A combined with the Argl9 
misincorporation mutation at position 19. The position 19 
substitution also addresses the specific role of Arg substitution 
at this position in window C. The combined mutation in 
BNP(GR14/R19) showed decreased NPR-C binding, about 
15 fold. In contrast BNP(GR14), changing hBNP to the cor- 
responding hANP sequence, showed decreased affinity to both 
receptors. Receptor selectivity from window A is then coming 
from the S19R misincorporation mutation; BNP(RI9) has 
both increased affinity to NPR-A and decreased NPR-C bind- 
ing, resulting in an overall relative improvement in NPR-A 
preference of 265 (Table 2). 
The mutation FWR was picked as representative of the 
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Table 1 
Sequences of selected hBNP variants ~
hBNP Randomization Window Relative b 
A-IgG 
A B g D Binding 
Clone 10 15 20 25 (mutant/ 
Number ~ ~G" "O I $ S S S G L G C hANP) # of clones 
i G R R 1.6 I0 
2 G P N R >20 4 
3 T R S Q 4.2 i0 
4 N RH L 1.0 1 
5 N ARE 1.3 1 
6 N NKT 4.2 3 
7 N GRA 4.8 1 
8 Q R H S T 4.0 2 
9 N R 3.5 i 
i0  T R H G H 5.0 2 
I i  MWR 1.0 7 
12 FWR 0.8 7 
13 MY R 2.4 2 
14 LWR 2.0 3 
15  MFR 3.0 1 
Four libraries of mutant BNP display phage were created by random- 
ization of three or four adjacent codons in the disulfide bonded ring 
sequence of BNP (randomization windows A-D). Display phages 
were enriched by one round of panning on the NPR-A ECD fusion 
protein A-IgG, then subjected to seven rounds of competitive panning 
with immobilized A-IgG and solution phase C-IgG. 14-20 individual 
clones from each selection were sequenced and analyzed for receptor 
binding by phage ELISA (see corresponding clone numbers in Fig. 2). 
Selectants from randomization window B all had reduced binding to 
A-IgG. 
~The 17 amino acid sequence of the disulfide linked hBNP ring is 
shown in single letter code. For the complete hBNP sequence see 
Fig. 1. 
bValues in bold are derived from the data in Fig. 2A. 
selectivity changes found in window D (Table 1). The syn- 
thetic peptide BNP(FWR25) showed both enhanced NPR-A 
binding and decreased NPR-C binding for an overall 8.7-fold 
increase in NPR-A preference. Whereas the native 23, 24, 25 
sequence GLG is conserved in hBNP and hANP (Fig. 1), the 
FWR mutation does not have analogous effects on ANP. The 
peptide ANP(FWR22) has decreased binding to NPR-A  
(l l .5-fold) and a minor effect on NPR-C binding (Table 2), 
demonstrating that these changes cannot be engrafted to 
hANP. 
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To determine if further improvement in receptor selectivity 
can be achieved, the combined mutant molecule BNP(R19/ 
FWR25) was synthesized. Compared to each mutation alone, 
R19 or FWR25, the combined mutations were intermediate in
improved NPR-A affinity. There is further impairment of 
NPR-C binding with the combined mutations, but the net 
effect on receptor selectivity (NPR-C/NPR-A preference) 
was comparable to the single S19R substitution in 
BNP(RI9) (Table 2). 
3.3. Agonist potency of BNP variants 
Native ligands and synthetic variants were tested tor ago- 
nist potency in stimulating NPR-A signal transduction. Con- 
centration-response or single-dose stimulations of cGMP pro- 
duction were done with cultured 293 cells expressing 
recombinant hNPR-A (Fig. 3, Table 3). Consistent with the 
binding data. BNP(GR14) had impaired activity, whereas 
BNP(GRI4/R 19) had restored activity (Fig. 3B). Interestingly, 
BNP(RI9) had enhanced stimulation of cGMP production 
which was apparently lost in the combination mutant 
BNP(GR14/R19). Enhanced stimulation was also observed 
for the other variants tested (Fig. 3A), with from 15 to 29(/,, 
higher plateau cGMP levels in the concentration response 
assay (Table 3). 
Enhancements in NPR-A affinity (Table 2) did not neces- 
sarily correlate with EDs0 for agonist potency (Table 3). Both 
BNP(R 19) and BNP(FWR25) had insignificant improvements 
in agonist potency compared to hBNP, whereas BNP(R19/ 
FWR25) had improved affinity but approximately 2-fold low- 
er agonist potency (Table 3). For ANP(FWR22) we observed 
both enhanced maximal stimulation of cGMP and about 15- 
fold reduced agonist potency (Table 3) compared to a 6-fold 
reduction in binding. 
4. Discussion 
In this report we describe the results of a competitive pan- 
ning experiment in which immobilized A- IgG and solution 
phase C-IgG were used to identify NPR-A selective hBNP 
variants expressed in libraries of mutant display phage. Sev- 
eral classes of mutations may be identified by this strategy 
including receptor selectivity, increased affinity for NPR-A, 
or increased secretion expression in E. co/i[9]. Previous work 
Table 2 
Receptor binding data for natriuretic peptide mutants 
Peptide Receptor binding Relative affinity ~ Fold-change 
IC50 (pM) (IC50 Mutant/IC;,0 WT) in selectivity ~'
NPR-A NPR-C NPR-A NPR-C 
hANP 44 + 13 198 + 90 1 1 I 
hBNP 645 + 298 1791 + 145 1 1 1 
BNP(GR14/RI9) 518 +_ 72 (2.8 _+ 1)x 101 0.8 15.6 19.5 
BNP(GR 14) (4.4 + 0.6) × 10 4 (1.4 -+ 1.3) × 104 68 7.8 0.11 
BNP(R19) 155 + 55 (9.5 + 1.5) × 104 0.2 53 265 
BNP(FWR25) 378 -+ 136 9363 + 2067 0.6 5.2 8.7 
ABP(FWR22) 507 -+ 118 295 + 57 11.5 1.5 0.13 
BNP(R19/FWR25) 287 + 27 (1.7 + 1.2) × 104 0.4 95 237 
Competitive binding experiments were done with membranes from human embryonic kidney 293 cells expressing full length hNPR-A or NPR-C, 
with serial dilutions of peptides and [125I]ANP as tracer. A single class of binding site was observed in each case. Data are the average of triplicate 
measurements _+ tandard eviation. 
'~Relative affinity is based on hANP as a reference for ANP(FWR22), and hBNP for each of the BNP peptides. 
bFold-change in selectivity is the ratio of relative affÉnities (NPR-C/NPR-A), with a number > 1 indicating reater preference for NPR-A relative to 
the native peptide. 
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with libraries of mutant ANP display phage found that recep- 
tor selectivity mutations were confined to the 17 amino acid 
disulfide bonded ring [9]. We obtained similar results with 
hBNP using the same strategy for mutagenesis window selec- 
tion. The choice of alternative mutagenesis windows may 
however give a different result. 
In two mutagenesis windows we found misincorporation 
mutations (positions 14 and 19) that occurred as a result of 
low frequency errors in the mutagenesis oligonucleotide. This 
is in contrast to the misincorporation mutation found in ANP 
as a result of polymerase rror [9], and highlights the sensi- 
tivity of the selection in identifying mutations that confer 
selectivity. 
Our results demonstrate hat a common feature shared by 
hBNP and hANP is the receptor selectivity afforded by Arg 
substitution at positions 19 or 16, respectively [9]. In both 
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Fig. 3. Stimulation of cGMP production. Concentration-response 
measurements for cGMP production (A) were performed with ANP, 
BNP, and analogs (see legend at right). Results are the average of 
3 determinations, and are plotted as a four parameter curve fit (see 
Section 2). Single-dose stimulation experiments (B) were done with 
several analogs at 40 nM concentration. Values plotted for ANP, 
BNP, BNP(FWR), BNP(S19R, FWR), BNP(S19R) and ANP(FWR) 
are taken from panel A. 
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Table 3 
Peptide agonist potency on hNPR-A 
Peptide EDs0 Maximum cGMP" 
(nM) (pmoles/well) 
hANP 0.43 + 0.04 1564 + 21 
hBNP 2.73 + 1.12 1476+ 88 
BNP(GR14/R 19) b 1-10 N.D. 
BNP(GR14) b > 100 N.D. 
BNP(RI 9) 1.67 + 0.24 1886 + 44 
BNP(FWR25) 1.77 + 0.03 1842 + 6 
ANP(FWR22) 2.00 + 0.45 1794 + 72 
BNP(R 19/FWR25) 6.8 + 1.1 2014 + 59 
Monolayer cultures of 293 cells stably expressing hNPR-A were 
stimulated with peptides for 10 rain and 37°C, and cGMP produced 
was measured by radioimmunoassay. ED~0 and Maximum cGMP 
values are derived from the concentration-responses and ingle con- 
centration stimulations plotted in Fig. 3. 
~N.D., not determined. 
bBased on single dose estimations from Fig. 3B. 
cases this substitution was detected by selection of a misin- 
corporation mutation outside the target mutagenesis window 
in addition to selection from within a window. In the case of 
hBNP this misincorporation mutation occurred in conjunc- 
tion with two substitutions within the mutagenesis window 
that change the hBNP sequence to that of hANP.  Our results 
with synthetic peptides how that these changes in window A 
are not involved in receptor selectivity and may be required 
for secretion expression of the Arg 19 hBNP fusion protein in 
E. coli. Window C mutations (Table 1) resulted in the selec- 
tion of basic residues at position 19 and/or 20, with a corre- 
sponding misincorporation mutation at position 14, Lys sub- 
stituted for a polar residue. As with ANP, the basic nature of 
the polypeptide (pI = 12) may not be favorable for optimal 
secretion expression, with the result that some selected muta- 
tions may in fact balance charge effects of selectivity changes. 
Although there are clearly similarities between hBNP and 
hANP in the Arg 19 or 16 mutation, the selectivity changes 
identified in the last mutagenesis window have no analog in 
ANP. These last 3 amino acids of the disulfide ring are con- 
served in hBNP and hANP (Fig. 1), as well as C-type natriu- 
retic peptide [2]. We can conclude from this result that there 
are different determinants of receptor specificity for hBNP 
and hANP in binding and activation of NPR-A. Whereas 
mutagenesis of these residues in hANP did not identify recep- 
tor selectivity mutations, the converse is true at the beginning 
of the ring. In this region, covering the first 4 residues of the 
ring, receptor selectivity mutations were identified for ANP 
[9], but our experiment (Table 1, window A) did not identify 
any hBNP selectivity mutations in this region. These data 
highlight fundamental differences in the mode of ligand rec- 
ognition by NPR-C and NPR-A. This conclusion is also true 
for cross-species comparisons of NPR-A and NPR-C, with 
divergent modes of recognition for both ANP and BNP var- 
iants [14-16]. Together these observations suggest hat each 
receptor/ligand pair will have some unique structural determi- 
nants of specificity and affinity, perhaps reflected in a variable 
contour and different side-chain contacts at the receptor/ 
ligand interface. 
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